Echosens, Novo Nordisk Partner to Boost MASH Awareness
August 18, 2025
Echosens, the leader in non-invasive liver diagnostics, and Novo Nordisk are strengthening their aligned efforts to combat steatotic liver disease, following the U.S. Food and Drug Administration’s